SAB Biotherapeutics SABS
NASDAQ SABS
$3.17 -0.05 (-1.55%)
At close: Sep 30, 2026 · 4:00 PM EDT

SAB Biotherapeutics (SABS) Accounts Payables (2020 - 2026)

Updated

SAB Biotherapeutics (SABS) posted Accounts Payables of $7.21 million for Q2 2026, up 1.7% from $7.09 million a year earlier and up 33.8% from the prior quarter.

Analysis

SAB Biotherapeutics (SABS) Accounts Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, SAB Biotherapeutics' Accounts Payables came in at $6.58 million, up 20.3% from FY2024.

  • Annual Accounts Payables shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • In prior years, SAB Biotherapeutics' Accounts Payables was $5.47 million in FY2024 (-18.2%), $6.69 million in FY2023 (-32.5%), $9.92 million in FY2022 (-20.4%) and $12.46 million in FY2021 (+68.7%).
  • The Q2 2026 figure stands as the highest quarterly Accounts Payables since Q1 2023.
  • On a year-over-year basis, Accounts Payables increased in five of the last eight quarters, with growth averaging 9.9%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2021, with growth of 68.7%; the weakest was Q3 2023, with a decline of 48.2%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $5.39 million (Q1 2026), $6.58 million (Q4 2025) and $6.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 SAB Biotherapeutics 268.85 Mn 268.85 Mn - 7.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.21 Mn
Mar 31, 2026 5.39 Mn
Dec 31, 2025 6.58 Mn
Sep 30, 2025 6.85 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 6.06 Mn
Dec 31, 2024 5.47 Mn
Sep 30, 2024 6.88 Mn
Jun 30, 2024 5.05 Mn
Mar 31, 2024 5.17 Mn
Dec 31, 2023 6.69 Mn
Sep 30, 2023 5.30 Mn
Jun 30, 2023 5.93 Mn
Mar 31, 2023 8.19 Mn
Dec 31, 2022 9.92 Mn
Sep 30, 2022 10.24 Mn
Jun 30, 2022 9.86 Mn
Mar 31, 2022 11.86 Mn
Dec 31, 2021 12.46 Mn
Dec 31, 2020 7.38 Mn
API Access

SAB Biotherapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=SABS&period=max&api_key=YOUR_API_KEY